187 related articles for article (PubMed ID: 28152659)
1. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
[TBL] [Abstract][Full Text] [Related]
2. Primary lymphoma of CNS, mycophenolate mofetil and lupus.
Finelli PF; Naik K; DiGiuseppe JA; Prasad A
Lupus; 2006; 15(12):886-8. PubMed ID: 17211996
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
[TBL] [Abstract][Full Text] [Related]
4. Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis.
Lai GG; Koo YX; Tao M; Tan TT; Lim ST
Acta Oncol; 2011 Jan; 50(1):144-5. PubMed ID: 20670084
[No Abstract] [Full Text] [Related]
5. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: A case report and review of literature.
Su L; Ding M; Chen L; Li C; Lao M
Medicine (Baltimore); 2018 Jun; 97(23):e11072. PubMed ID: 29879076
[TBL] [Abstract][Full Text] [Related]
6. Listeria monocytogenes meningoencephalitis during the treatment with rituximab and mycophenolate mofetil in a patient with pediatric-onset systemic lupus erythematosus.
Sifuentes Giraldo WA; Guillén Astete CA; Amil Casas I; Gámir Gámir ML
Reumatol Clin; 2015; 11(2):125-6. PubMed ID: 25150501
[No Abstract] [Full Text] [Related]
7. Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.
Svobodova B; Hruskova Z; Rysava R; Tesar V
Lupus; 2011 Nov; 20(13):1452-4. PubMed ID: 21868432
[No Abstract] [Full Text] [Related]
8. Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: A case report and literature review.
Sakairi T; Nakasatomi M; Watanabe M; Hamatani H; Ikeuchi H; Kaneko Y; Handa H; Hiromura K
Mod Rheumatol Case Rep; 2022 Jan; 6(1):36-40. PubMed ID: 34505624
[TBL] [Abstract][Full Text] [Related]
9. [Central nervous system lymphoma revealed by lymphocytic meningitis in a patient with systemic lupus erythematosus: An unusual association].
Roriz M; Lopes A; Jarrin I; Lechtman S; Polivka M; Bergmann JF; Sène D; Mouly S
Rev Med Interne; 2017 Apr; 38(4):269-273. PubMed ID: 27363932
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H
Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis.
Dasgupta N; Gelber AC; Racke F; Fine DM
Lupus; 2005; 14(11):910-3. PubMed ID: 16335585
[TBL] [Abstract][Full Text] [Related]
12. Natalizumab-associated central nervous system lymphoma?--another patient.
Matzke M; Schreiber S; Elolf E; Metz I; Mawrin C; Heinze HJ; Sailer M
Mult Scler; 2012 Nov; 18(11):1653-4. PubMed ID: 22383229
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.
Gaubitz M; Schorat A; Schotte H; Kern P; Domschke W
Lupus; 1999; 8(9):731-6. PubMed ID: 10602445
[TBL] [Abstract][Full Text] [Related]
14. Colitis and Pancreatitis in a Patient with Systemic Lupus Erythematosus: Due to Disease or to Drug?
Paleti S; Yarlagadda B; Gremida A; Aziz M; Hanson J; McCarthy D
Dig Dis Sci; 2018 Sep; 63(9):2206-2209. PubMed ID: 30069857
[No Abstract] [Full Text] [Related]
15. Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus.
Turno-Kręcicka A; Tomczyk-Socha M; Zimny A
Lupus; 2016 Dec; 25(14):1610-1614. PubMed ID: 27178013
[TBL] [Abstract][Full Text] [Related]
16. Acute inflammatory syndrome following introduction of mycophenolate mofetil in a patient with systemic lupus erythematosus.
Konon I; Cronin ME; Ryan LM
Arthritis Rheum; 2008 May; 59(5):754-6. PubMed ID: 18438909
[No Abstract] [Full Text] [Related]
17. Disseminated cryptococcosis as a complication of lupus nephritis.
Beji S; Hajji M; El Kateb H; Kosai I; Jebali H; Kheder R; Fatma LB; Rais L; Laameri L; Krid M; Zouaghi K
Saudi J Kidney Dis Transpl; 2017; 28(6):1435-1439. PubMed ID: 29265061
[TBL] [Abstract][Full Text] [Related]
18. Pseudo-Pelger-Huët anomaly in a 58-year-old woman treated with mycophenolate mofetil for flare of systemic lupus erythematosus.
Zhao Y; Rehder C; Wang E
Int J Lab Hematol; 2021 Feb; 43(1):3-4. PubMed ID: 33206453
[No Abstract] [Full Text] [Related]
19. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus.
Doherty T; Austin SK; Newell B; Kiely PD
Lupus; 2013 Feb; 22(2):213-5. PubMed ID: 23257406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
